Insights on Clinical Trials
-
Rheumatoid Arthritis – Global Clinical Trial Landscape
3/11/2024
While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.
-
Global Prevalence And Clinical Trials Landscape Of DMD
3/11/2024
Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.
-
Do ClinOps Professionals Understand The CAR-T Supply Chain?
3/4/2024
Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials.
-
How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges
3/1/2024
Learn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
FDA’s Updated Guidance On Human Genome Editing: New Implications & Remaining Questions
2/27/2024
On Jan. 29, 2024, the FDA released the final version of the guidance document on human gene therapy products incorporating genome editing. This article shares what changed between the draft and now final version of the guidance, and what open questions remain for the industry and scientific community to help resolve.
-
Site Feasibility Tips For Cell And Gene Therapy Clinical Trials
2/22/2024
Site feasibility assessment can be challenging. Therefore, it’s essential to have a solid understanding of the regulatory obligations for investigators and sites when it comes to choosing each.
-
What Are Hybrid Trials Like For Patients?
2/21/2024
When a patient has the choice to have a more convenient trial, recruitment and enrollment increase, and retention is improved as dropout rates are reduced. Learn how patient-centric trial delivery can keep patients engaged.
-
Alofisel P3 Cell Therapy Facility
2/21/2024
Despite various issues with a client's CQV project, CAI delivered the project on time and significantly contributed to the delivery of the first ATMP facility in Ireland.
-
Modernize TMF Culture To Better Support Modern Clinical Trials
2/21/2024
Clear benefits emerge when TMF is made a more engaging and less overwhelming task for all who must collaborate to complete it.
-
How Sponsors And Patients Benefit From A Site-Centric Partnership
2/21/2024
Creating a site-centric partnership between a pharmaceutical/biopharmaceutical sponsor and a clinical trial site can ease personnel and patient burdens, driving high-quality data collection and documentation.